Are There Foreign Investment Incentives in Bozhou’s TCM Sector?
Yes. Foreign investors in Bozhou’s Traditional Chinese Medicine (TCM) sector can access at least 8 dedicated incentive categories, including tax holidays, land subsidies, and R&D grants. Bozhou, the “Chinese Medicine Capital of China,” reported a TCM industry output value of approximately RMB 80 billion in 2023, accounting for over 90% of Anhui’s TCM industry output. The municipal government has issued specific policies to attract foreign capital, particularly for 外商独资企业 (Wholly Foreign-Owned Enterprise, WFOE, wàishāng dúzī qǐyè) focused on processing, extraction, and bio-pharmaceutical R&D. The core policy document is the “Bozhou TCM Industry Development Several Policies” (亳州市促进中医药发展若干政策, Bózhōu shì cùjìn zhōngyīyào fāzhǎn ruògān zhèngcè), which was updated in 2023.
What Types of Incentives Are Available?
Bozhou’s incentives are structured to attract foreign capital across the TCM value chain—from raw material processing to finished product manufacturing and biotech R&D. The city offers a combination of financial rewards, land cost reductions, and streamlined approval procedures. Below is a breakdown of the main categories:
| Incentive Category | Maximum Benefit | Eligibility Criteria |
|---|---|---|
| Corporate Income Tax Holiday | Reduced to 15% for 3 years (from 25%) | WFOEs engaged in TCM extraction or bio-pharma R&D |
| Land Use Fee Subsidy | Up to 50% reduction for 10-year lease | Factory projects > RMB 50 million investment |
| R&D Expense Grant | Up to RMB 5 million per project | Approved TCM clinical research or drug registration |
| Product Registration Bonus | RMB 2 million for Class 1 TCM drugs | First approval of new TCM drug in China |
| GMP Certification Support | RMB 500,000 lump sum | Foreign-invested factory achieving GMP by 2025 |
| Loan Interest Subsidy | 3% of annual interest for 5 years (cap: RMB 3 million) | WFOE or joint venture producing TCM granules |
| Export Logistics Subsidy | RMB 5 per kg of exported TCM raw material | Annual export volume > 100 tons |
| Fast-Track Licensing | Administrative approval within 15 days (vs. 30+ normally) | Foreign-invested R&D centers |
Which TCM Sub-Sectors Offer the Best Incentive Rates?
Not all TCM sub-sectors in Bozhou are treated equally. The local government prioritizes high-value, technology-intensive activities over basic raw material trading. The best incentive rates apply to TCM extraction and purification lines (中药提取和纯化, zhōngyào tíqǔ hé chúnhuà), as well as bio-pharmaceutical contract research organizations (CROs). For example, a WFOE building a TCM extraction plant with total investment exceeding RMB 200 million can qualify for a corporate income tax rate of just 15% for the first three years—a 40% reduction from the standard 25% CIT rate. By comparison, a simple TCM packaging or trading company typically gets only the loan interest subsidy and land fee reduction.
If your project involves TCM drug registration as a “Class 1” product (equivalent to new molecular entity), the city offers a bonus of RMB 2 million upon first approval. To put this in perspective, Bozhou recorded 18 foreign-invested TCM projects in 2023, with total committed FDI of USD 320 million. The city’s goal is to reach USD 600 million by 2028, making this an attractive window for early movers.
Decision Framework
Use this framework to determine which incentive package matches your business model:
- If you are a biopharma company conducting clinical trials for a new TCM drug (Class 1 or 2), choose the R&D Expense Grant + Product Registration Bonus combination. This yields up to RMB 7 million in direct cash incentives.
- If you are a contract manufacturer for TCM granules or extracts (GMP required), choose the Land Use Fee Subsidy + GMP Certification Support + Loan Interest Subsidy. This can reduce total setup cost by 25-30%.
- If you are a trading company exporting TCM raw materials, choose the Export Logistics Subsidy + Fast-Track Licensing. This optimizes logistics cost and customs clearance time.
Pitfalls to Avoid
How to Apply for These Incentives?
The application process is centralized in the Bozhou Investment Promotion Center (亳州市投资促进中心, Bózhōu shì tóuzī cùjìn zhōngxīn). Foreign investors must file a Project Filing Form (项目备案表, xiàngmù bèiàn biǎo) with the center, along with feasibility study, business registration proof (WFOE or JV), and a commitment letter. The standard approval timeline is 30 working days for most incentives. For the Class 1 drug bonus, separate review by the Anhui Provincial Medical Products Administration is required, adding 45 days. A dedicated foreign investment hotline is available at 0558-5123456 (English-speaking staff available during business hours).
NEXT STEPS
- Review the full policy text in Chinese: Request the latest “Bozhou TCM Industry Development Several Policies (2023 Edition)” from our team. Download the official Chinese PDF and English executive summary here.
- Engage a local legal partner: Incentive eligibility often hinges on corporate and registration structure. Set up your WFOE in Anhui with our recommended legal services provider.
- Visit Bozhou for a site inspection: The city offers a RMB 10,000 subsidy for foreign investors who travel to Bozhou for a face-to-face investment meeting. Book this through our Anhui Gateway site inspection program.
— Anhui Gateway —
Remote China market entry support, built around execution.